LITH Company Profile and Key Details

The stock is currently mid-range between its 52-week high and low $0.00 and $0.00. With a market capitalization of about $941.00, BioELife Corp. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.50). Key stats such as the average daily volume over the past year has been around 438.00 shares, volume is running light vs its 52-week average. Headquartered in Seal Beach, CA, BioELife Corp. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Michael Terpin, the company employs approximately 1 people and listed since August 07, 2009. BioELife Corp. operates in cannabinoid market.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Our AI price prediction model suggests that BioELife Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows BioELife Corp. trading at a premium to the broader market with a P/E of -0.0.

BioELife Corp. trades at a P/E ratio of -0.0, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 The P/FCF stands at -0.01, also above market averages.